# New entrants and the unbundling of the hospital
A knee replacement that once meant a two-night hospital stay now happens at a freestanding surgery center, and the patient drives home the same afternoon. The procedure is the same. The economics are not. That single shift, replicated across thousands of procedures, is the story of hospital unbundling: challengers slicing off a hospital's most profitable outpatient work and leaving the rest behind.
This lesson maps who is doing the slicing, what incumbents defend, cede, or buy, and where the margin ends up.
A traditional hospital is a bundle. It cross-subsidizes. High-margin services (elective orthopedic surgery, cardiology, advanced imaging) fund low-margin or money-losing ones (the emergency department, trauma, behavioral health, uninsured care).
That bundle held together because, for decades, a knee replacement or a colonoscopy legitimately needed a full inpatient facility: overnight monitoring, an operating suite, anesthesia backup on site.
Two things broke the bundle:
Once a procedure is safe outside the hospital, a focused competitor can do just that one thing, cheaper and often better, without carrying the emergency department.
An ASC is a freestanding facility for same-day surgical procedures. This is the sharpest threat because ASCs target exactly the high-margin surgical cases that anchored the hospital bundle: orthopedics, gastroenterology, ophthalmology (cataracts), pain management.
The largest US operators are real and large: Surgery Partners, and USPI (United Surgical Partners International, majority owned by Tenet Healthcare). Many ASCs are joint ventures with the surgeons who use them, which aligns physician incentives against the local hospital.
The regulatory tailwind is concrete. The US Medicare program (the federal insurance program for people 65+) publishes an "ASC covered procedures list" and has expanded it over the years, letting more procedures be reimbursed in the ASC setting. See the CMS overview of Ambulatory Surgical Center Payment.
Urgent care chains (for example CityMD, MedExpress) handle sprains, minor infections, and stitches: the low-acuity end of the emergency department. They cede nothing valuable back to the hospital; they simply divert volume.
Retail clinics sit inside pharmacies and stores. The recent history here is a caution: CVS Health operates MinuteClinic, but Walmart Health and Walgreens' heavily funded VillageMD strategy both retrenched sharply in 2024 and 2025. Retail primary care proved hard to run profitably. Lesson: unbundling is not automatic; execution and unit economics matter.
Telehealth challengers (Teladoc, and Amazon's Amazon One Medical / Amazon Clinic) target routine visits, prescription refills, and follow-ups. Payment for telehealth expanded dramatically during the COVID-19 pandemic. Some of those flexibilities have been extended by Congress on a temporary basis rather than made permanent, so the reimbursement rules remain a moving target into 2026. Treat any specific coverage rule as time-sensitive.
Watch the payers themselves. UnitedHealth Group's Optum now employs or is affiliated with a very large number of US physicians (commonly cited figures are in the tens of thousands, an estimate that shifts). When an insurer owns the doctors and the surgery centers, it can steer patients away from hospitals on purpose. This is vertical integration used as a competitive weapon.
Here is the mechanism in a simplified, illustrative example. These numbers are illustrative, not real reimbursement rates.
Imagine a hospital's outpatient service line:
| Case type | Volume | Margin per case | Total margin |
|---|---|---|---|
| Orthopedic surgery | 1,000 | +$4,000 | +$4,000,000 |
| Imaging | 2,000 | +$800 | +$1,600,000 |
| Emergency dept | 10,000 | -$300 | -$3,000,000 |
| Net | | | +$2,600,000 |
Now an ASC opens and captures 60% of the orthopedic surgery:
The hospital still runs the loss-making emergency department. Its profitable anchor just walked out the door. That is the whole game in one table: challengers take the profit centers, incumbents keep the cost centers.
This is why hospital leaders describe ASCs not as "competition" but as an existential margin threat.
Faced with unbundling, hospitals and health systems do three things.
Keep and fortify what cannot easily be unbundled:
Deliberately give up low-value, high-hassle volume. Some systems are happy to let urgent care take minor cases that clog the emergency department. Ceding can be rational.
The dominant response since roughly 2020: if you cannot beat the ASC, own one. Health systems now build or joint-venture their own ambulatory surgery centers, often with the surgeons, so the margin stays inside the system even as the setting shifts. Large nonprofit systems (for example Advocate Health, HCA Healthcare on the for-profit side) have expanded ambulatory footprints aggressively.
This is the key strategic insight: incumbents are not just defending the hospital. They are trying to become the unbundler themselves before someone else does.
Knowledge check
1. Why does the hospital 'bundle' rely on cross-subsidization?
2. What best explains why ambulatory surgery centers represent 'the sharpest threat' to hospitals?
3. A focused competitor can perform a single procedure 'cheaper and often better' than a full hospital primarily because it:
4. Select ALL correct answers. Which developments broke apart the traditional hospital bundle?
Select all the correct answers.
5. Select ALL correct answers. Which statements accurately describe the logic of hospital 'unbundling'?
Select all the correct answers.
MapMapUsing software to automate repetitive marketing tasks and campaigns, enabling personalisation at scale across channels like email, web, and social.View full definition → the balance of power across the chain:
The margin, once pooled inside the hospital, is now being redistributed toward whoever controls the profitable outpatient case: increasingly the payer-plus-physician-plus-ASC combination, not the hospital building.
In Europe the dynamic is muted where systems are public. In the UK's National Health Service (NHS), "unbundling" appears as independent-sector treatment centers handling elective procedures (hip and knee replacements, cataracts) to cut waiting lists, contracted by the public system rather than competing for margin. In Germany and France, private hospital groups (for example Fresenius Helios in Germany, Ramsay Santé in France) run day-surgery clinics, but heavy price regulation limits the cherry-picking incentive that drives the US market. The clinical shift to outpatient is universal; the profit-seeking scramble is strongest where prices are least regulated.